Search alternatives:
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
661
-
662
-
663
-
664
-
665
-
666
SU9518 decreases cell proliferation and restore normal remodeling in eNOS (−/−) mice.
Published 2012“…(E) PDGF-BB receptor tyrosine kinase inhibitor decreases immunoreactive survivin levels in LC of eNOS (−/−) mice, compared to vehicle treated eNOS (−/−) mice (left panel). …”
-
667
-
668
-
669
GluN2A(D731N) decreases channel open probability.
Published 2017“…The di-heteromeric mutant (2A-D731N) and tri-heteromeric receptors with two-copies of the mutant subunit (D731N/D731N) showed a prolonged inhibition rate, reflecting a decreased channel open probability. …”
-
670
-
671
-
672
-
673
-
674
-
675
A Novel Highly Potent Autotaxin/ENPP2 Inhibitor Produces Prolonged Decreases in Plasma Lysophosphatidic Acid Formation <i>In Vivo</i> and Regulates Urethral Tension
Published 2014“…To date, several autotaxin/ENPP2 inhibitors have been reported; however, none were able to completely and continuously inhibit autotaxin/ENPP2 <i>in vivo</i>. In this study, we report the discovery of a highly potent autotaxin/ENPP2 inhibitor, ONO-8430506, which decreased plasma lysophosphatidic acid formation.…”
-
676
Loss of p115RhoGEF decreases junctional E-cadherin and promotes protrusions.
Published 2014“…D) Quantitation of the ratio of junctional over cytoplasmic E-cadherin in MCF7 and MCF10A cells treated with p115RhoGEF siRNA showed a significant decrease (mean ± S.E.) in junctional E-cadherin as compared to cells treated with control siRNA. …”
-
677
-
678
-
679
-
680